Efficacy of dapagliflozin in improving arrhythmia-related outcomes after ablation for atrial fibrillation: a retrospective single-center study
ConclusionDAPA administration post-ablation was associated with significantly reduced atrial arrhythmia recurrence rates, indicating its potential as an adjunct therapy for enhancing the success of AF ablation.Graphical abstract
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiology | Cardiovascular | Dapagliflozin | Forxiga | Heart | Sodium | Study